View Future GrowthReplenish Nutrients Holding 과거 순이익 실적과거 기준 점검 0/6Replenish Nutrients Holding 의 수입은 연평균 -5.3%의 비율로 감소해 온 반면, Chemicals 산업은 연평균 4.4%의 비율로 감소했습니다. 매출은 연평균 6.2%의 비율로 감소해 왔습니다.핵심 정보-5.30%순이익 성장률19.04%주당순이익(EPS) 성장률Chemicals 산업 성장률12.41%매출 성장률-6.20%자기자본이익률-132.42%순이익률-135.51%최근 순이익 업데이트31 Mar 2026최근 과거 실적 업데이트Reported Earnings • May 29First quarter 2026 earnings released: CA$0.01 loss per share (vs CA$0.009 loss in 1Q 2025)First quarter 2026 results: CA$0.01 loss per share (further deteriorated from CA$0.009 loss in 1Q 2025). Revenue: CA$417.3k (up 3.9% from 1Q 2025). Net loss: CA$1.83m (loss widened 50% from 1Q 2025). Over the last 3 years on average, earnings per share has fallen by 27% per year but the company’s share price has increased by 16% per year, which means it is well ahead of earnings.Reported Earnings • Aug 30Second quarter 2024 earnings released: CA$0.01 loss per share (vs CA$0.004 loss in 2Q 2023)Second quarter 2024 results: CA$0.01 loss per share (further deteriorated from CA$0.004 loss in 2Q 2023). Revenue: CA$882.8k (down 79% from 2Q 2023). Net loss: CA$1.34m (loss widened 139% from 2Q 2023). Over the last 3 years on average, earnings per share has increased by 54% per year but the company’s share price has fallen by 47% per year, which means it is significantly lagging earnings.Reported Earnings • Jun 04First quarter 2024 earnings released: CA$0.01 loss per share (vs CA$0.002 loss in 1Q 2023)First quarter 2024 results: CA$0.01 loss per share (further deteriorated from CA$0.002 loss in 1Q 2023). Revenue: CA$1.34m (down 46% from 1Q 2023). Net loss: CA$1.56m (loss widened 490% from 1Q 2023). Over the last 3 years on average, earnings per share has increased by 48% per year but the company’s share price has fallen by 46% per year, which means it is significantly lagging earnings.Reported Earnings • May 02Full year 2023 earnings releasedFull year 2023 results: Revenue: CA$13.9m (down 19% from FY 2022). Net income: CA$84.2k (up CA$7.17m from FY 2022). Profit margin: 0.6% (up from net loss in FY 2022). Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has fallen by 44% per year, which means it is significantly lagging earnings.Reported Earnings • Dec 01Third quarter 2023 earnings releasedThird quarter 2023 results: Revenue: CA$3.55m (up 31% from 3Q 2022). Net loss: CA$33.7k (loss narrowed 97% from 3Q 2022). Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has fallen by 46% per year, which means it is significantly lagging earnings.Reported Earnings • Sep 03Second quarter 2023 earnings released: CA$0.024 loss per share (vs CA$0.012 loss in 2Q 2022)Second quarter 2023 results: CA$0.024 loss per share. Revenue: CA$4.30m (down 39% from 2Q 2022). Net loss: CA$563.9k (loss narrowed 56% from 2Q 2022).모든 업데이트 보기Recent updatesNew Risk • May 29New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -CA$3.4m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CA$3.4m free cash flow). Share price has been highly volatile over the past 3 months (22% average weekly change). Earnings have declined by 5.3% per year over the past 5 years. Minor Risks Shareholders have been diluted in the past year (28% increase in shares outstanding). Revenue is less than US$5m (CA$6.8m revenue, or US$5.0m). Market cap is less than US$100m (€17.9m market cap, or US$20.9m).Reported Earnings • May 29First quarter 2026 earnings released: CA$0.01 loss per share (vs CA$0.009 loss in 1Q 2025)First quarter 2026 results: CA$0.01 loss per share (further deteriorated from CA$0.009 loss in 1Q 2025). Revenue: CA$417.3k (up 3.9% from 1Q 2025). Net loss: CA$1.83m (loss widened 50% from 1Q 2025). Over the last 3 years on average, earnings per share has fallen by 27% per year but the company’s share price has increased by 16% per year, which means it is well ahead of earnings.공시 • Apr 14Replenish Nutrients Holding Corp Secures $250,000 In Sustainable CAP Funding To Support Beiseker Facility Scale UpReplenish Nutrients Holding Corp. had been approved for a grant of up to $250,000 funded by the governments of Canada and Alberta under the Sustainable Canadian Agricultural Partnership (Sustainable CAP) Value-Added Program. The funding is designated for the Beiseker Granulation project, supporting the Company's previous 2025 capital investments in fertilizer processing equipment at its Beiseker, Alberta facility. This facility recently achieved significant operational milestones, reaching sustained production rates of 45 metric tonnes per hour as it transitions toward full-scale commercial operations. The facility's targeted output is approximately 2,000 metric tonnes per month once final conveyance, load-out systems, and 24-hour operations are fully implemented. The Sustainable CAP Value-Added Program supports the continued diversification, innovation, growth and prosperity of Alberta's value-added food and bio-industrial sectors. For Replenish, the grant provides funding for the expansion of the Company's proprietary zero-waste fertilizer manufacturing facility. The Sustainable Canadian Agricultural Partnership (Sustainable CAP) is a 5-year (2023-2028), $3.5-billion investment by the federal, provincial and territorial governments to strengthen the competitiveness, innovation and resiliency of Canada's agriculture, agri-food and agri-based products sector. This includes $1 billion in federal programs and activities, and $2.5-billion commitment that is cost-shared 60% federally and 40% provincially/territorially for programs that are designed and delivered by provinces and territories. The grant offsets eligible capital investments incurred in 2025 related to the procurement and installation of specialized processing equipment, including advanced granulation components, dryers, and automated controls at the Company's Beiseker facility. These upgrades support Replenish's 2026 growth strategy, which focuses on increasing production throughput, improving operational efficiency, and enhancing cash flow visibility as the Beiseker facility transitions toward steady-state commercial production.공시 • Apr 07Replenish Nutrients Holding Corp., Annual General Meeting, Jun 19, 2026Replenish Nutrients Holding Corp., Annual General Meeting, Jun 19, 2026.공시 • Apr 01Replenish Nutrients Holding Corp. announced that it has received CAD 4.061383 million in funding from Sorbie Bornholm LPOn March 31, 2026, Replenish Nutrients Holding Corp. closed the transaction. The company issued 3,745,667 units for aggregate gross proceeds of approximately CAD 449,480 in its third and final tranche. All of the securities issued under the Offering are subject to a four-month and one-day statutory hold period. In connection with the third tranche of the Offering, the Company paid an aggregate of CAD 13,444 in finder's fees and issued, in aggregate, 48,020 finder's warrants, entitling the holder thereof to purchase one Common Share at a price of CAD 0.18 for a period of 24 months following the issue date.공시 • Jan 19Replenish Nutrients Holding Corp. announced that it expects to receive CAD 3 million in fundingReplenish Nutrients Holding Corp. announced a non-brokered private placement of 25,000,000 units at a price of CAD 0.12 per unit for aggregate proceeds of up to CAD 3,000,000 on January 19, 2026. Each unit will consist of one common share and one common share purchase warrant, with each warrant entitling the holder to purchase one common share at an exercise price of CAD 0.18 per common share for a period of 24 months following the issue date. The closing of the offering is expected to occur on or about February 2, 2026. In accordance with applicable securities laws, all units issued under the offering will be subject to a hold period expiring four months and one day following the date of issue of the units. Closing of the offering is subject to certain conditions including the receipt of all necessary regulatory approvals including the approval of the Canadian Securities Exchange. Certain directors and officers of the company have advised that they expect to subscribe for units in the offering. The transaction will include participation from new investor Sorbie Bornholm LP for CAD 1,950,000.공시 • May 05Replenish Nutrients Holding Corp., Annual General Meeting, Jun 25, 2025Replenish Nutrients Holding Corp., Annual General Meeting, Jun 25, 2025.공시 • Apr 24Replenish Nutrients Holding Corp. announced that it has received CAD 1.484589 million in fundingOn April 24, 2025 Replenish Nutrients Holding Corp. closed the oversubscribed private placement. The company issued 6,710,100 units at an issue price of CAD 0.08 per unit for gross proceeds of CAD 536,808 in its second and final tranche. The issuance of 2,160,100 units, in aggregate, to certain insiders of the company under the second tranche of the offering. All of the securities issued under the offering are subject to a four-month and one-day statutory hold period. The company did not pay any finder's fees in cash or securities under the offering.공시 • Apr 02Replenish Nutrients Holding Corp. announced that it expects to receive CAD 1 million in fundingReplenish Nutrients Holding Corp announced a non-brokered private placement to issue minimum of 8,750,000 units and maximum of 12,500,000 units at an issue price of CAD 0.08 per unit for gross proceeds of minimum of CAD 700,000 and maximum of CAD 1,000,000 on April 2, 2025. Each Unit will consist of one common share and one Common Share purchase warrant, each whole Warrant entitling the holder to purchase one Common Share at an exercise price of CAD 0.12 per Common Share for a period of two years following the issue date. Closing of the Offering and Debt Settlement is expected to occur on or about April 17, 2025. In accordance with applicable securities laws, all Units issued under the Offering and Debt Settlement will be subject to a hold period expiring four months and a day following the date of issue of the Units. Closing of the Offering and Debt Settlement is subject to certain conditions including the receipt of all necessary regulatory approvals including the approval of the Canadian Securities Exchange. Certain directors and officers of the Company have advised that they expect to subscribe for Units in the Offering.Reported Earnings • Aug 30Second quarter 2024 earnings released: CA$0.01 loss per share (vs CA$0.004 loss in 2Q 2023)Second quarter 2024 results: CA$0.01 loss per share (further deteriorated from CA$0.004 loss in 2Q 2023). Revenue: CA$882.8k (down 79% from 2Q 2023). Net loss: CA$1.34m (loss widened 139% from 2Q 2023). Over the last 3 years on average, earnings per share has increased by 54% per year but the company’s share price has fallen by 47% per year, which means it is significantly lagging earnings.Reported Earnings • Jun 04First quarter 2024 earnings released: CA$0.01 loss per share (vs CA$0.002 loss in 1Q 2023)First quarter 2024 results: CA$0.01 loss per share (further deteriorated from CA$0.002 loss in 1Q 2023). Revenue: CA$1.34m (down 46% from 1Q 2023). Net loss: CA$1.56m (loss widened 490% from 1Q 2023). Over the last 3 years on average, earnings per share has increased by 48% per year but the company’s share price has fallen by 46% per year, which means it is significantly lagging earnings.Reported Earnings • May 02Full year 2023 earnings releasedFull year 2023 results: Revenue: CA$13.9m (down 19% from FY 2022). Net income: CA$84.2k (up CA$7.17m from FY 2022). Profit margin: 0.6% (up from net loss in FY 2022). Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has fallen by 44% per year, which means it is significantly lagging earnings.공시 • Apr 13Replenish Nutrients Holding Corp., Annual General Meeting, Jun 26, 2024Replenish Nutrients Holding Corp., Annual General Meeting, Jun 26, 2024.Reported Earnings • Dec 01Third quarter 2023 earnings releasedThird quarter 2023 results: Revenue: CA$3.55m (up 31% from 3Q 2022). Net loss: CA$33.7k (loss narrowed 97% from 3Q 2022). Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has fallen by 46% per year, which means it is significantly lagging earnings.Board Change • Sep 07Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Chris Best was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Sep 03Second quarter 2023 earnings released: CA$0.024 loss per share (vs CA$0.012 loss in 2Q 2022)Second quarter 2023 results: CA$0.024 loss per share. Revenue: CA$4.30m (down 39% from 2Q 2022). Net loss: CA$563.9k (loss narrowed 56% from 2Q 2022).Reported Earnings • Jun 01First quarter 2023 earnings releasedFirst quarter 2023 results: Revenue: CA$2.49m (down 19% from 1Q 2022). Net loss: CA$264.1k (loss narrowed 81% from 1Q 2022). Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has fallen by 41% per year, which means it is significantly lagging earnings.Reported Earnings • May 03Full year 2022 earnings released: CA$0.06 loss per share (vs CA$0.063 loss in FY 2021)Full year 2022 results: CA$0.06 loss per share. Revenue: CA$17.3m (up 40% from FY 2021). Net loss: CA$7.08m (loss widened 51% from FY 2021).Reported Earnings • Dec 01Third quarter 2022 earnings released: CA$0.008 loss per share (vs CA$0.029 loss in 3Q 2021)Third quarter 2022 results: CA$0.008 loss per share (improved from CA$0.029 loss in 3Q 2021). Revenue: CA$2.72m (up 19% from 3Q 2021). Net loss: CA$1.08m (loss narrowed 56% from 3Q 2021).Reported Earnings • Aug 31Second quarter 2022 earnings released: CA$0.012 loss per share (vs CA$0.017 loss in 2Q 2021)Second quarter 2022 results: CA$0.012 loss per share. Revenue: CA$7.03m (up 344% from 2Q 2021). Net loss: CA$1.29m (loss widened 21% from 2Q 2021).Reported Earnings • May 04Full year 2021 earnings released: CA$0.063 loss per share (vs CA$0.083 loss in FY 2020)Full year 2021 results: CA$0.063 loss per share. Revenue: CA$12.3m (up CA$11.8m from FY 2020). Net loss: CA$4.70m (loss widened 21% from FY 2020).Reported Earnings • Nov 30Third quarter 2021 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2021 results: CA$0.029 loss per share (down from CA$0.019 loss in 3Q 2020). Revenue: CA$2.56m (up CA$2.42m from 3Q 2020). Net loss: CA$2.42m (loss widened 155% from 3Q 2020). Revenue was in line with analyst estimates.Reported Earnings • Aug 28Second quarter 2021 earnings released: CA$0.017 loss per share (vs CA$0.03 loss in 2Q 2020)The company reported a solid second quarter result with reduced losses, improved revenues and improved control over expenses. Second quarter 2021 results: Revenue: CA$1.59m (up CA$1.52m from 2Q 2020). Net loss: CA$1.06m (loss narrowed 20% from 2Q 2020).Reported Earnings • May 23First quarter 2021 earnings released: CA$0.014 loss per share (vs CA$0.018 loss in 1Q 2020)The company reported a solid first quarter result with improved revenues and control over costs, although losses increased. First quarter 2021 results: Revenue: CA$481.7k (up 232% from 1Q 2020). Net loss: CA$790.1k (loss widened 16% from 1Q 2020).Reported Earnings • Apr 22Full year 2020 earnings released: CA$0.083 loss per share (vs CA$0.047 loss in FY 2019)The company reported a decent full year result with improved revenues, although losses increased and control over costs was weaker. Full year 2020 results: Revenue: CA$506.9k (up 177% from FY 2019). Net loss: CA$3.88m (loss widened 182% from FY 2019).Is New 90 Day High Low • Feb 18New 90-day high: €0.35The company is up 104% from its price of €0.17 on 19 November 2020. The German market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 14% over the same period.Is New 90 Day High Low • Jan 13New 90-day high: €0.23The company is up 22% from its price of €0.19 on 15 October 2020. The German market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 17% over the same period.Recent Insider Transactions • Nov 25Independent Chairman of the Board recently bought €129k worth of stockOn the 23rd of November, Frederic Leigh bought around 750k shares on-market at roughly €0.17 per share. In the last 3 months, they made an even bigger purchase worth €272k. Frederic has been a buyer over the last 12 months, purchasing a net total of €179k worth in shares.Reported Earnings • Nov 21Third quarter 2020 earnings released: CA$0.019 loss per shareThe company reported a decent third quarter result with improved revenues, although control over expenses were weaker and an increased loss. Third quarter 2020 results: Revenue: CA$139.4k (up 196% from 3Q 2019). Net loss: CA$949.4k (loss widened 308% from 3Q 2019).Recent Insider Transactions • Oct 18Independent Chairman of the Board recently bought €272k worth of stockOn the 13th of October, Frederic Leigh bought around 2m shares on-market at roughly €0.18 per share. This was the largest purchase by an insider in the last 3 months. Frederic has been a buyer over the last 12 months, purchasing a net total of €50k worth in shares.매출 및 비용 세부 내역Replenish Nutrients Holding가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이DB:7KE 매출, 비용 및 순이익 (CAD Millions)날짜매출순이익일반관리비연구개발비31 Mar 267-93031 Dec 257-93030 Sep 256-73030 Jun 257-43031 Mar 256-43031 Dec 247-43130 Sep 24803130 Jun 249-23131 Mar 2413-13031 Dec 231403030 Sep 2315-42030 Jun 2314-53031 Mar 2317-63031 Dec 2217-73030 Sep 2221-45030 Jun 2220-65031 Mar 2215-55031 Dec 2112-56030 Sep 214-54030 Jun 212-44031 Mar 211-44031 Dec 201-43030 Sep 200-33030 Jun 200-33031 Mar 200-22031 Dec 190-11030 Sep 190-51030 Jun 190-51031 Mar 190-51031 Dec 180-51030 Sep 18000031 Dec 17020031 Dec 160-11031 Dec 150-100양질의 수익: 7KE 은(는) 현재 수익성이 없습니다.이익 마진 증가: 7KE는 현재 수익성이 없습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: 7KE은 수익성이 없으며 지난 5년 동안 손실이 연평균 5.3% 증가했습니다.성장 가속화: 현재 수익성이 없어 지난 1년간 7KE의 수익 성장률을 5년 평균과 비교할 수 없습니다.수익 대 산업: 7KE은 수익성이 없어 지난 해 수익 성장률을 Chemicals 업계(-13.5%)와 비교하기 어렵습니다.자기자본이익률높은 ROE: 7KE는 현재 수익성이 없으므로 자본 수익률이 음수(-132.42%)입니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YMaterials 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/06/07 20:01종가2026/06/05 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Replenish Nutrients Holding Corp.는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
Reported Earnings • May 29First quarter 2026 earnings released: CA$0.01 loss per share (vs CA$0.009 loss in 1Q 2025)First quarter 2026 results: CA$0.01 loss per share (further deteriorated from CA$0.009 loss in 1Q 2025). Revenue: CA$417.3k (up 3.9% from 1Q 2025). Net loss: CA$1.83m (loss widened 50% from 1Q 2025). Over the last 3 years on average, earnings per share has fallen by 27% per year but the company’s share price has increased by 16% per year, which means it is well ahead of earnings.
Reported Earnings • Aug 30Second quarter 2024 earnings released: CA$0.01 loss per share (vs CA$0.004 loss in 2Q 2023)Second quarter 2024 results: CA$0.01 loss per share (further deteriorated from CA$0.004 loss in 2Q 2023). Revenue: CA$882.8k (down 79% from 2Q 2023). Net loss: CA$1.34m (loss widened 139% from 2Q 2023). Over the last 3 years on average, earnings per share has increased by 54% per year but the company’s share price has fallen by 47% per year, which means it is significantly lagging earnings.
Reported Earnings • Jun 04First quarter 2024 earnings released: CA$0.01 loss per share (vs CA$0.002 loss in 1Q 2023)First quarter 2024 results: CA$0.01 loss per share (further deteriorated from CA$0.002 loss in 1Q 2023). Revenue: CA$1.34m (down 46% from 1Q 2023). Net loss: CA$1.56m (loss widened 490% from 1Q 2023). Over the last 3 years on average, earnings per share has increased by 48% per year but the company’s share price has fallen by 46% per year, which means it is significantly lagging earnings.
Reported Earnings • May 02Full year 2023 earnings releasedFull year 2023 results: Revenue: CA$13.9m (down 19% from FY 2022). Net income: CA$84.2k (up CA$7.17m from FY 2022). Profit margin: 0.6% (up from net loss in FY 2022). Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has fallen by 44% per year, which means it is significantly lagging earnings.
Reported Earnings • Dec 01Third quarter 2023 earnings releasedThird quarter 2023 results: Revenue: CA$3.55m (up 31% from 3Q 2022). Net loss: CA$33.7k (loss narrowed 97% from 3Q 2022). Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has fallen by 46% per year, which means it is significantly lagging earnings.
Reported Earnings • Sep 03Second quarter 2023 earnings released: CA$0.024 loss per share (vs CA$0.012 loss in 2Q 2022)Second quarter 2023 results: CA$0.024 loss per share. Revenue: CA$4.30m (down 39% from 2Q 2022). Net loss: CA$563.9k (loss narrowed 56% from 2Q 2022).
New Risk • May 29New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -CA$3.4m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CA$3.4m free cash flow). Share price has been highly volatile over the past 3 months (22% average weekly change). Earnings have declined by 5.3% per year over the past 5 years. Minor Risks Shareholders have been diluted in the past year (28% increase in shares outstanding). Revenue is less than US$5m (CA$6.8m revenue, or US$5.0m). Market cap is less than US$100m (€17.9m market cap, or US$20.9m).
Reported Earnings • May 29First quarter 2026 earnings released: CA$0.01 loss per share (vs CA$0.009 loss in 1Q 2025)First quarter 2026 results: CA$0.01 loss per share (further deteriorated from CA$0.009 loss in 1Q 2025). Revenue: CA$417.3k (up 3.9% from 1Q 2025). Net loss: CA$1.83m (loss widened 50% from 1Q 2025). Over the last 3 years on average, earnings per share has fallen by 27% per year but the company’s share price has increased by 16% per year, which means it is well ahead of earnings.
공시 • Apr 14Replenish Nutrients Holding Corp Secures $250,000 In Sustainable CAP Funding To Support Beiseker Facility Scale UpReplenish Nutrients Holding Corp. had been approved for a grant of up to $250,000 funded by the governments of Canada and Alberta under the Sustainable Canadian Agricultural Partnership (Sustainable CAP) Value-Added Program. The funding is designated for the Beiseker Granulation project, supporting the Company's previous 2025 capital investments in fertilizer processing equipment at its Beiseker, Alberta facility. This facility recently achieved significant operational milestones, reaching sustained production rates of 45 metric tonnes per hour as it transitions toward full-scale commercial operations. The facility's targeted output is approximately 2,000 metric tonnes per month once final conveyance, load-out systems, and 24-hour operations are fully implemented. The Sustainable CAP Value-Added Program supports the continued diversification, innovation, growth and prosperity of Alberta's value-added food and bio-industrial sectors. For Replenish, the grant provides funding for the expansion of the Company's proprietary zero-waste fertilizer manufacturing facility. The Sustainable Canadian Agricultural Partnership (Sustainable CAP) is a 5-year (2023-2028), $3.5-billion investment by the federal, provincial and territorial governments to strengthen the competitiveness, innovation and resiliency of Canada's agriculture, agri-food and agri-based products sector. This includes $1 billion in federal programs and activities, and $2.5-billion commitment that is cost-shared 60% federally and 40% provincially/territorially for programs that are designed and delivered by provinces and territories. The grant offsets eligible capital investments incurred in 2025 related to the procurement and installation of specialized processing equipment, including advanced granulation components, dryers, and automated controls at the Company's Beiseker facility. These upgrades support Replenish's 2026 growth strategy, which focuses on increasing production throughput, improving operational efficiency, and enhancing cash flow visibility as the Beiseker facility transitions toward steady-state commercial production.
공시 • Apr 07Replenish Nutrients Holding Corp., Annual General Meeting, Jun 19, 2026Replenish Nutrients Holding Corp., Annual General Meeting, Jun 19, 2026.
공시 • Apr 01Replenish Nutrients Holding Corp. announced that it has received CAD 4.061383 million in funding from Sorbie Bornholm LPOn March 31, 2026, Replenish Nutrients Holding Corp. closed the transaction. The company issued 3,745,667 units for aggregate gross proceeds of approximately CAD 449,480 in its third and final tranche. All of the securities issued under the Offering are subject to a four-month and one-day statutory hold period. In connection with the third tranche of the Offering, the Company paid an aggregate of CAD 13,444 in finder's fees and issued, in aggregate, 48,020 finder's warrants, entitling the holder thereof to purchase one Common Share at a price of CAD 0.18 for a period of 24 months following the issue date.
공시 • Jan 19Replenish Nutrients Holding Corp. announced that it expects to receive CAD 3 million in fundingReplenish Nutrients Holding Corp. announced a non-brokered private placement of 25,000,000 units at a price of CAD 0.12 per unit for aggregate proceeds of up to CAD 3,000,000 on January 19, 2026. Each unit will consist of one common share and one common share purchase warrant, with each warrant entitling the holder to purchase one common share at an exercise price of CAD 0.18 per common share for a period of 24 months following the issue date. The closing of the offering is expected to occur on or about February 2, 2026. In accordance with applicable securities laws, all units issued under the offering will be subject to a hold period expiring four months and one day following the date of issue of the units. Closing of the offering is subject to certain conditions including the receipt of all necessary regulatory approvals including the approval of the Canadian Securities Exchange. Certain directors and officers of the company have advised that they expect to subscribe for units in the offering. The transaction will include participation from new investor Sorbie Bornholm LP for CAD 1,950,000.
공시 • May 05Replenish Nutrients Holding Corp., Annual General Meeting, Jun 25, 2025Replenish Nutrients Holding Corp., Annual General Meeting, Jun 25, 2025.
공시 • Apr 24Replenish Nutrients Holding Corp. announced that it has received CAD 1.484589 million in fundingOn April 24, 2025 Replenish Nutrients Holding Corp. closed the oversubscribed private placement. The company issued 6,710,100 units at an issue price of CAD 0.08 per unit for gross proceeds of CAD 536,808 in its second and final tranche. The issuance of 2,160,100 units, in aggregate, to certain insiders of the company under the second tranche of the offering. All of the securities issued under the offering are subject to a four-month and one-day statutory hold period. The company did not pay any finder's fees in cash or securities under the offering.
공시 • Apr 02Replenish Nutrients Holding Corp. announced that it expects to receive CAD 1 million in fundingReplenish Nutrients Holding Corp announced a non-brokered private placement to issue minimum of 8,750,000 units and maximum of 12,500,000 units at an issue price of CAD 0.08 per unit for gross proceeds of minimum of CAD 700,000 and maximum of CAD 1,000,000 on April 2, 2025. Each Unit will consist of one common share and one Common Share purchase warrant, each whole Warrant entitling the holder to purchase one Common Share at an exercise price of CAD 0.12 per Common Share for a period of two years following the issue date. Closing of the Offering and Debt Settlement is expected to occur on or about April 17, 2025. In accordance with applicable securities laws, all Units issued under the Offering and Debt Settlement will be subject to a hold period expiring four months and a day following the date of issue of the Units. Closing of the Offering and Debt Settlement is subject to certain conditions including the receipt of all necessary regulatory approvals including the approval of the Canadian Securities Exchange. Certain directors and officers of the Company have advised that they expect to subscribe for Units in the Offering.
Reported Earnings • Aug 30Second quarter 2024 earnings released: CA$0.01 loss per share (vs CA$0.004 loss in 2Q 2023)Second quarter 2024 results: CA$0.01 loss per share (further deteriorated from CA$0.004 loss in 2Q 2023). Revenue: CA$882.8k (down 79% from 2Q 2023). Net loss: CA$1.34m (loss widened 139% from 2Q 2023). Over the last 3 years on average, earnings per share has increased by 54% per year but the company’s share price has fallen by 47% per year, which means it is significantly lagging earnings.
Reported Earnings • Jun 04First quarter 2024 earnings released: CA$0.01 loss per share (vs CA$0.002 loss in 1Q 2023)First quarter 2024 results: CA$0.01 loss per share (further deteriorated from CA$0.002 loss in 1Q 2023). Revenue: CA$1.34m (down 46% from 1Q 2023). Net loss: CA$1.56m (loss widened 490% from 1Q 2023). Over the last 3 years on average, earnings per share has increased by 48% per year but the company’s share price has fallen by 46% per year, which means it is significantly lagging earnings.
Reported Earnings • May 02Full year 2023 earnings releasedFull year 2023 results: Revenue: CA$13.9m (down 19% from FY 2022). Net income: CA$84.2k (up CA$7.17m from FY 2022). Profit margin: 0.6% (up from net loss in FY 2022). Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has fallen by 44% per year, which means it is significantly lagging earnings.
공시 • Apr 13Replenish Nutrients Holding Corp., Annual General Meeting, Jun 26, 2024Replenish Nutrients Holding Corp., Annual General Meeting, Jun 26, 2024.
Reported Earnings • Dec 01Third quarter 2023 earnings releasedThird quarter 2023 results: Revenue: CA$3.55m (up 31% from 3Q 2022). Net loss: CA$33.7k (loss narrowed 97% from 3Q 2022). Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has fallen by 46% per year, which means it is significantly lagging earnings.
Board Change • Sep 07Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Chris Best was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Sep 03Second quarter 2023 earnings released: CA$0.024 loss per share (vs CA$0.012 loss in 2Q 2022)Second quarter 2023 results: CA$0.024 loss per share. Revenue: CA$4.30m (down 39% from 2Q 2022). Net loss: CA$563.9k (loss narrowed 56% from 2Q 2022).
Reported Earnings • Jun 01First quarter 2023 earnings releasedFirst quarter 2023 results: Revenue: CA$2.49m (down 19% from 1Q 2022). Net loss: CA$264.1k (loss narrowed 81% from 1Q 2022). Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has fallen by 41% per year, which means it is significantly lagging earnings.
Reported Earnings • May 03Full year 2022 earnings released: CA$0.06 loss per share (vs CA$0.063 loss in FY 2021)Full year 2022 results: CA$0.06 loss per share. Revenue: CA$17.3m (up 40% from FY 2021). Net loss: CA$7.08m (loss widened 51% from FY 2021).
Reported Earnings • Dec 01Third quarter 2022 earnings released: CA$0.008 loss per share (vs CA$0.029 loss in 3Q 2021)Third quarter 2022 results: CA$0.008 loss per share (improved from CA$0.029 loss in 3Q 2021). Revenue: CA$2.72m (up 19% from 3Q 2021). Net loss: CA$1.08m (loss narrowed 56% from 3Q 2021).
Reported Earnings • Aug 31Second quarter 2022 earnings released: CA$0.012 loss per share (vs CA$0.017 loss in 2Q 2021)Second quarter 2022 results: CA$0.012 loss per share. Revenue: CA$7.03m (up 344% from 2Q 2021). Net loss: CA$1.29m (loss widened 21% from 2Q 2021).
Reported Earnings • May 04Full year 2021 earnings released: CA$0.063 loss per share (vs CA$0.083 loss in FY 2020)Full year 2021 results: CA$0.063 loss per share. Revenue: CA$12.3m (up CA$11.8m from FY 2020). Net loss: CA$4.70m (loss widened 21% from FY 2020).
Reported Earnings • Nov 30Third quarter 2021 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2021 results: CA$0.029 loss per share (down from CA$0.019 loss in 3Q 2020). Revenue: CA$2.56m (up CA$2.42m from 3Q 2020). Net loss: CA$2.42m (loss widened 155% from 3Q 2020). Revenue was in line with analyst estimates.
Reported Earnings • Aug 28Second quarter 2021 earnings released: CA$0.017 loss per share (vs CA$0.03 loss in 2Q 2020)The company reported a solid second quarter result with reduced losses, improved revenues and improved control over expenses. Second quarter 2021 results: Revenue: CA$1.59m (up CA$1.52m from 2Q 2020). Net loss: CA$1.06m (loss narrowed 20% from 2Q 2020).
Reported Earnings • May 23First quarter 2021 earnings released: CA$0.014 loss per share (vs CA$0.018 loss in 1Q 2020)The company reported a solid first quarter result with improved revenues and control over costs, although losses increased. First quarter 2021 results: Revenue: CA$481.7k (up 232% from 1Q 2020). Net loss: CA$790.1k (loss widened 16% from 1Q 2020).
Reported Earnings • Apr 22Full year 2020 earnings released: CA$0.083 loss per share (vs CA$0.047 loss in FY 2019)The company reported a decent full year result with improved revenues, although losses increased and control over costs was weaker. Full year 2020 results: Revenue: CA$506.9k (up 177% from FY 2019). Net loss: CA$3.88m (loss widened 182% from FY 2019).
Is New 90 Day High Low • Feb 18New 90-day high: €0.35The company is up 104% from its price of €0.17 on 19 November 2020. The German market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 14% over the same period.
Is New 90 Day High Low • Jan 13New 90-day high: €0.23The company is up 22% from its price of €0.19 on 15 October 2020. The German market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 17% over the same period.
Recent Insider Transactions • Nov 25Independent Chairman of the Board recently bought €129k worth of stockOn the 23rd of November, Frederic Leigh bought around 750k shares on-market at roughly €0.17 per share. In the last 3 months, they made an even bigger purchase worth €272k. Frederic has been a buyer over the last 12 months, purchasing a net total of €179k worth in shares.
Reported Earnings • Nov 21Third quarter 2020 earnings released: CA$0.019 loss per shareThe company reported a decent third quarter result with improved revenues, although control over expenses were weaker and an increased loss. Third quarter 2020 results: Revenue: CA$139.4k (up 196% from 3Q 2019). Net loss: CA$949.4k (loss widened 308% from 3Q 2019).
Recent Insider Transactions • Oct 18Independent Chairman of the Board recently bought €272k worth of stockOn the 13th of October, Frederic Leigh bought around 2m shares on-market at roughly €0.18 per share. This was the largest purchase by an insider in the last 3 months. Frederic has been a buyer over the last 12 months, purchasing a net total of €50k worth in shares.